EU Regulator Backs a Three-Month HIV Prevention Ring for Women

EU Regulator Backs a Three-Month HIV Prevention Ring for Women

EU Regulator Backs a Three-Month HIV Prevention Ring for Women

#news#HIV#PrEP#Dating

Women now have one more HIV prevention option on the way, and this one only needs changing four times a year. In meeting highlights published November 13, the European Medicines Agency's human medicines committee (CHMP) said it had recommended a new 100 mg strength of the dapivirine vaginal ring. The new ring can be replaced every three months instead of every month. Its developer, the Population Council, announced the news on November 16.

The ring is meant for countries outside Europe, mainly in Africa, and it is not available in the United States. Still, it is a good reminder of how fast HIV prevention is changing, and it points to something that matters to everyone who dates: having more prevention choices helps more people find one they can actually stick with.

What the EMA recommended

According to the EMA, the dapivirine ring is used to reduce the risk of HIV-1 infection through vaginal sex in women 16 and older. The new 100 mg strength lets the ring be replaced every three months instead of every month.

  • It is a scientific opinion, not an EU approval. The ring was reviewed under a procedure called EU-Medicines for all (EU-M4All). It lets the EMA assess medicines intended for use outside the European Union. Experts from the World Health Organization and regulators from Kenya, South Africa and Zambia took part in the review.
  • Each country still decides. National regulators decide whether to approve the product for their own markets.
  • Who it covers. The Population Council says the opinion supports use by women and adolescent girls 16 and older, including women who are breastfeeding.

How the ring works

The ring is a flexible silicone ring that a woman inserts into the vagina herself. It slowly releases dapivirine, an antiretroviral drug, right where HIV exposure can happen during vaginal sex. Dapivirine works by blocking HIV from copying itself inside healthy cells.

The original one-month ring received a positive EMA opinion in 2020. In January 2021, the WHO recommended it as an additional prevention choice for women at substantial risk of HIV, as part of a combination prevention approach. According to the Population Council, the one-month ring has since been approved in 12 African countries.

How well does it protect?

The ring is not the strongest HIV prevention tool available, and it helps to be clear about that. According to the WHO, two large phase 3 trials found that the monthly ring lowered HIV risk by 35% in the Ring Study and 27% in the ASPIRE study. In later open-label extension studies, women used the ring more consistently, and modeling suggested risk reduction of more than 50%. WHO also notes that analyses point to higher protection among women who used the ring consistently.

The three-month ring was not tested in a new efficacy trial. Its review included a phase 1 crossover study of 124 women in South Africa who used both the one-month and three-month rings. According to the Population Council, the three-month ring was well tolerated and delivered higher dapivirine levels, which suggests it should protect at least as well as the monthly ring.

Why fewer ring changes matter

A recurring challenge with PrEP is that prevention only works if people keep using it. Missed pills, missed clinic visits and the hassle of refills are common reasons people stop. With four rings a year instead of twelve, the Population Council says annual product costs should fall by nearly 60% compared with the unsubsidized price of the monthly ring. That matters as funding cuts put pressure on HIV programs. We saw a similar pattern with the twice-yearly PrEP shot, where more people stayed on PrEP than with daily pills.

The ring is also controlled by the woman using it. She does not have to take a daily pill and does not need a partner's cooperation to use it. For some women, that privacy and independence is what makes prevention possible at all.

Can you get it in the United States?

No. In December 2021, the ring's developer withdrew its US application after the FDA indicated that the available data were unlikely to support approval, given US HIV patterns and the prevention options already available to women here. WHO noted that this decision was not based on any new efficacy or safety data.

In the US, FDA-approved PrEP currently includes daily pills, a cabotegravir injection given every two months and a twice-yearly lenacapavir injection. Not every option is approved for every person or type of sex. For example, Descovy is not approved for people whose risk comes from receptive vaginal sex. A clinician can help you compare options. For more background, see our coverage of the first generic twice-yearly PrEP shot and the global push to reach 3 million people with it.

What this means if you are dating

  • The ring protects against HIV only. It is not a contraceptive, and it is not designed to protect against herpes, HPV, syphilis or other STIs. Our guide to what PrEP and doxyPEP do not protect against explains the gaps, and layering condoms, antivirals and PrEP covers how people combine tools.
  • U=U is still the strongest protection between partners. When a partner living with HIV takes treatment and stays undetectable, they do not transmit HIV through sex. Read more in our explainer on what U=U means for dating.
  • Mixed-status couples have more choices than ever. Treatment, PrEP and honest conversations work together. See our guide for serodiscordant couples.
  • Choice is a form of respect. Prevention works best when each person picks a method that fits their body, their routine and their privacy, without pressure from a partner.

The bottom line

The three-month dapivirine ring will not change prevention options in the US anytime soon. Even so, it is meaningful progress for women in the countries hit hardest by HIV, and part of a broader shift toward longer-acting, easier-to-use prevention. Talk with a licensed clinician about which prevention options fit your life, and keep testing for other STIs as part of your routine.

Looking for people who understand dating with HIV or another STI? Explore STD dating on MeetPositives.

Sources

  • European Medicines Agency. "Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026." November 13, 2026.
  • Population Council. "Population Council's Three-Month HIV Prevention Product Receives Positive Scientific Opinion from European Medicines Agency." November 16, 2026.
  • World Health Organization. "WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection." January 26, 2021.
  • World Health Organization. "WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV." December 9, 2021.

This article is for general information only and is not medical advice. It does not create a doctor-patient relationship. Talk with a licensed health care provider about your own situation.

Share This Story, Choose Your Platform!

About the author

Staff Writer

Comments (0)

Ask A Question

Have A Question, Personal Story, Or Situation You'd Like Help With? Share It Here. The More Context You Include, The More Thoughtful And Useful Our Guidance Can Be.

Our Editorial Team (And Occasional Relationship Contributors) May Choose Selected Submissions To Answer In An Upcoming Blog Post. All Submissions Are Reviewed And Published Anonymously—We Will Never Include Identifying Details.

Important:

If Your Question Is About Your Account, Billing, Upgrades, Reports, Or Technical Issues, Please Contact Customer Care Through The Help Pages So We Can Assist You Faster.

Tips For A Better Answer (Optional):

  • Your Age Range + What You're Looking For (Dating, Friendship, Support)
  • What You've Tried So Far
  • What You're Hoping Happens Next
  • Any Boundaries Or Dealbreakers You Want Respected

200 Characters Left. Keep Going!

Responses Shared Here Are For General Information Only And Aren't Medical, Legal, Or Mental-Health Advice.

We Can't Provide Real-Time Or One-On-One Support Through This Form.